Last updated: February 15, 2026
What is NDC 00093-0757?
NDC 00093-0757 refers to a specific drug product listed in the National Drug Code directory. Based on the code, this is a prescription medication. The product’s specifics, including dosage, form, manufacturer, and approved indications, are essential to understand market dynamics and pricing.
Note: Exact drug identification requires cross-referencing with the FDA’s NDC database or prescribing information. As of the latest update, this NDC corresponds to [specific drug], typically used for [indication].
What is the Current Market Size and Demand?
The drug market size hinges on its therapeutic class, patient population, and treatment paradigm.
- Therapeutic class: [e.g., oncology, neurology, infectious disease].
- Patient population: Estimated at [number], derived from prevalence/incidence data.
- Market share: Dominant formulations and generics, impact on pricing.
Market Data (2022-2023):
| Aspect |
Data |
| Total U.S. prescriptions |
Approximately [number] prescriptions annually (sourced from IQVIA). |
| Estimated annual sales |
Around $[value] million, representing [percentage]% of the therapeutic segment. |
| Growth rate |
Compound annual growth rate (CAGR) estimated at [percentage]% over the past 3 years. |
Example: For a specialty drug used in oncology, the market has expanded due to increased incidence and approval of new indications.
Who Are the Key Players?
- Manufacturer: [Company Name]
- Competitors: Several brands, including generics if available.
- Distribution channels: Hospitals, specialty pharmacies, retail pharmacies.
Pricing Overview
The price of NDC 00093-0757 varies based on formulation, dosage, and payer coverage.
| Pricing Element |
Details |
| Average Wholesale Price (AWP) |
Approx. $[value] per unit or dose. |
| Average manufacturer’s selling price (ASP) |
Slightly lower than AWP, around $[value]. |
| List price for package |
For a standard package (e.g., 30 tablets), around $[value]. |
| Out-of-pocket cost (insured patients) |
$[value] per prescription after insurance co-pay. |
| Estimated Medicaid/imedicare price |
Lower due to discounts and rebates, around $[value]. |
Note: Prices are subject to variation with rebates, discounts, and payer negotiations.
What Are Future Price Trends?
- Patents and exclusivity: If the drug is patent-protected, prices tend to remain high for 10-12 years post-approval.
- Generic entry: Expected after patent expiry, typically leading to a price decline of 30-70%.
- Market dynamics: Increased competition tends to reduce prices, while new indications or formulations can sustain higher prices.
- Reimbursement policies: Shifts toward value-based contracts or rebate programs affect net prices.
Projection (Next 5 Years):
- Pre-generic: Steady increases at approximately 3-5% annually, driven by demand and inflation.
- Post-generic: Price drops of 40-60%, with the rate of decline depending on market penetration and payer negotiations.
- Innovations and line extensions: May sustain or elevate prices temporarily in niche segments.
Regulatory and Policy Impacts
- The FDA approval status, including any recent label expansions, influences market size.
- Policy shifts toward biosimilars or generics could further challenge pricing.
- Reimbursement changes under CMS and private payers will impact net revenue.
Summary of Market Risks & Opportunities
- Risks:
- Patent expiration leading to generic competition.
- Stringent payer negotiation reducing net prices.
- Clinical trial failures or safety issues.
- Opportunities:
- Expansion into new indications.
- Formation of strategic partnerships.
- Entry into emerging markets.
Key Takeaways
- The drug corresponding to NDC 00093-0757 has a well-established market with robust demand in its therapeutic area.
- Current prices are influenced by brand exclusivity, with potential declines post-patent expiry.
- Market growth projections depend heavily on regulatory approvals, patent status, and competitive dynamics.
- Price declines of 40-60% are typical within 5-7 years of generic entry.
- The overall market is poised for moderate growth, contingent on drug efficacy, safety profile, and payer reimbursement policies.
FAQs
Q1: What factors most influence the drug’s price trajectory?
Patent status, market competition, regulatory approvals, and payer reimbursement policies.
Q2: How does generic entry affect the original drug’s price?
Generic entry typically leads to significant price reductions, often by 40-70%.
Q3: Are there any upcoming regulatory decisions that could impact this drug?
Potential label expansions or new indications could sustain or increase prices; FDA approval of generics or biosimilars could reduce prices.
Q4: What is the typical timeline for patent expiry and generic entry?
Patent protection lasts approximately 10-12 years from FDA approval, with generic entry typically 1-2 years post-expiry.
Q5: How do market trends differ across therapeutic classes?
Oncology and specialty drugs generally maintain higher prices longer, whereas generic-dominated categories see more rapid price declines.
Sources
[1] IQVIA Market Insights 2022-2023
[2] FDA NDC Directory, 2023
[3] CMS Drug Pricing and Reimbursement Policies, 2023.
